Skip to content

MicroRNA expression profiles of blood in cardiovascular disease

MicroRNA expression profiles of blood in cardiovascular disease - MiRNAs in CVD

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON35241
Enrollment
80
Registered
2009-11-30
Start date
2009-12-02
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary artery disease coronary atherosclerosis

Interventions

nvt

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Cases: men with coronair artery disease under the age of 51 years and a positive family history of premature CVD. Controls: matched for sex, age and smoking habits

Exclusion criteria

Exclusion criteria: Cases: no cardiovascular event below 51 years Controles: history or complaints of cardiovascular disease, positive family history of cardiovascular disease, use of medication. Additional exclusion criteria because of carbasaalcalcium and statin administration: - Allergy for carbasalaatcalcium or simvastatin. - Liver function disorders defined as the upper normal limit of ALAT and ASAT - CPK above three time upper normal limit - Renal impairement Additional exclusion criteria for carbasalaatcalcium use: - Gastric pain or complaints with former use - Gastric bleeding or perforations - Ulcers in stomach, esophagus or bowels - Hypoprothrombinemia Additional exclusion criteria for statin use: - Consumption of excessive amount of alcohol defined as 21 units/week - Hypothyoidism - Familiar muscle disorders

Design outcomes

Primary

MeasureTime frame
MiRNA expression patterns of thrombocytes, monocytes, plasma and endothelial cells.

Secondary

MeasureTime frame
nvt

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)